Template:RSI guidelines
Jump to navigation
Jump to search
RSI guidelines - collection of American, Canadian, European guidelines Rapid Sequence Intubation (RSI)
| Parameter | Description | Type | Status | |||
|---|---|---|---|---|---|---|
| No parameters specified | ||||||
Eastern Association for the Surgery of Trauma (EAST) Emergency tracheal intubation immediately following traumatic injury, 2012[1]
An RSI drug regimen should be given to achieve the following clinical objectives:
- Adequate sedation and neuromuscular blockade,
- Maintenance of hemodynamic stability and CNS perfusion,
- Maintenance of adequate oxygenation,
- Prevention of increases in intracranial hypertension, and
- Prevention of vomiting and aspiration.
Acute Cardiac Life Support suggest the following viable options for induction agents:
- Etomidate 0.2-0.3 mg/kg IV
- Ketamine 1-2 mg/kg IV
- Methohexital 1-1.5 mg/kg IV
- Propofol 1.5-2.5 mg/kg IV in adults
- Propofol 2.5-3.5 mg/kg IV in children
- Propofol 1-1.5 mg/kg IV in elderly patients
- Thiopental 2-5 mg/kg IV